NYSE · Healthcare · Medical Instruments & Supplies · USA
Solventum Corp is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Solventum develops, manufactures, and commercializes healthcare solutions across three segments: MedSurg provides wound care, surgical supplies, and medical devices; Dental Solutions offers dental and orthodontic products; and Health Information Systems delivers software for healthcare administration and revenue cycle management. The company serves hospitals, clinics, dental practices, and healthcare systems worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Solventum Corp stock.
Undervalued: intrinsic value $163.56 per share, market price $85.05, margin of safety 48.0% (as of 2026-10-19).
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $163.56; the price of $85.05 is 48% below that value, and 79% of that value comes from beyond year five.
Leak Score: 72/100 on 7 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
SOLV is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $163.56; the price of $85.05 is 48% below that value, and 79% of that value comes from beyond year five.
$163.56 per share (as of the 2026-10-19 close), against a market price of $85.05. That is a margin of safety of 48.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
72 out of 100, which we rate "Clear Leak", on 7 of 12 value investing signals.